9 In addition, many candidates are only considered for SCS after standard pain treatment options have failed. "As the benefits of spinal cord stimulation technology become more widely understood and available, Abbott’s Eterna SCS System advances our options and ability to treat and relieve pain with this drug-free technology, giving patients a new lease on life and a greater sense of control.”Īccording to the Canadian Medical Association Journal, there is low awareness of SCS as an option for pain management. Michel Prud’homme, neurosurgeon from Hôpital de l'Enfant-Jésus hospital. "I witness the physical and mental toll of chronic pain on my patients, their relentless pursuit for relief, and the urgent need for new options,” shares Dr. 8 To tackle the negative impact of chronic pain, the Canadian Pain Task Force report calls for greater access to safe and effective treatment options, and more specialized pain services. 7 Additionally, unmanaged pain can lead to other health and societal issues, including mental health challenges and substance abuse. 6 Beyond the emotional and physical toll, chronic pain has profound economic implications with an estimated annual cost of $40 billion to the healthcare system and lost productivity. In Canada, one in five people aged 15 years and older live with chronic pain. The Eterna SCS system uses Abbott’s proprietary BurstDR (TM) stimulation, the only SCS technology with the highest level of clinical evidence (level 1A.) Abbott’s proprietary BurstDR™ therapy is proven to reduce pain by 23 per cent more than traditional tonic stimulation without the tingling sensation. The inaugural use case of the Eterna SCS system took place at Hôpital de l'Enfant-Jésus hospital in Quebec City, marking a significant milestone in the Canadian adoption of this technology by making it widely accessible for people suffering from chronic pain. MONTRÉAL, QC Ma-Abbott today announced that the company’s Eterna™ SCS system – the smallest implantable, rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain,* 3,4 has been used for the first time in Canada. The device is the smallest implantable rechargeable spinal cord stimulator (SCS) *3 and provides the ability to deliver therapy while only requiring wireless recharging five times per year, 1,2 meaning less frequent charging for the chronic pain patients being treated.Abbott’s Eterna™ SCS system to treat chronic pain was used for the first time in Canada at Hôpital de l'Enfant-Jésus hospital in Quebec City.
0 Comments
Leave a Reply. |